Humira®
Humira is an anti-TNF monoclonal antibody that currently treats
Crohn's disease, rheumatoid arthritis, ulcerative colitis,
hidradenitis suppurativa, psoriasis, psoriatic arthritis, juvenile
idiopathic arthritis, ankylosing spondylitis and uveitis.
Type of Molecule
BiologicTarget
TNFProduct Type
New Indication| Potential Indication | Region | Phase (1, 2, 3, Submitted, Approved) |
|---|---|---|
| Hidradenitis Suppurativa (HS) (US, EU) | US, EU |
Approved
|
| Uveitis (US, EU, Japan) | US, EU, JPN |
Approved
|